5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone,
GW 5074,
GW-5074,
GW5074,
gw5074,
220904-83-6,
GW 5074,
GW-5074,
Raf1 Kinase Inhibitor I,
UNII-B7W8RS1GG2,
B7W8RS1GG2,
CHEMBL72365,
InSolution™ Raf1 Kinase Inhibitor I,
5-Iodo-3-[(3,5-dibromo-4-hydroxyphenyl)methylene]-2-indolinone,
3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydro-indol-2-one,
(3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one,
3-(3,5-dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one,
(Z)-3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one,
SR-01000075897,
STO521,
3-(3,5-Dibromo-4-hydroxybenzyliden)-5-iodo-1,3-dihydroindol-2-one,
GW5074 Z-isomer,
GW5074, powder,
Tocris-1381,
BiomolKI_000056,
GW-5074 Z-isomer,
Lopac-G-6416,
BiomolKI2_000062,
AC1O00KW,
C15H8Br2INO2,
Lopac0_000510,
BMK1-F8,
BSPBio_001275,
SCHEMBL149921,
GTPL8072,
3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one,
BCBcMAP01_000125,
DTXSID10421368,
EX-A889,
HMS1362O17,
HMS1792O17,
HMS1990O17,
HMS3261F21,
HMS3403O17,
HMS3676K12,
BCP06316,
Tox21_500510,
2453AH,
BDBM50085415,
EI-307,
HSCI1_000002,
ZINC16052818,
AKOS024456562,
CCG-100660,
CCG-221814,
CS-0092,
RL02681,
SB19424,
IDI1_002223,
NCGC00015478-01,
NCGC00015478-02,
NCGC00015478-03,
NCGC00015478-04,
NCGC00015478-05,
NCGC00015478-06,
NCGC00015478-07,
NCGC00015478-09,
NCGC00025134-01,
NCGC00025134-02,
NCGC00025134-03,
NCGC00025134-04,
NCGC00025134-05,
NCGC00025134-06,
NCGC00261195-01,
HY-10542,
SC-25119,
GW-5074, (Z)-,
G6416 (GW5074),
RT-013138,
EU-0100510,
S2872,
EC-000.2403,
G 6416,
K00053,
W-5440,
J-510576,
SR-01000075897-1,
SR-01000075897-3,
BRD-K07859598-001-03-9,
3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodo-1,3-di,
UNII-P0LE4QW0S6 component LMXYVLFTZRPNRV-KMKOMSMNSA-N,
3-(3, 5-Dibromo-4-hydroxybenzylidine-5-iodo-1,3-dihydro-indol-2-one),
3-(3,5-Dibromo-4-hydroxy-benzylidene)-5-iodo-1,3-dihydr o-indol-2-one,
(3Z)-3-((3,5-Dibromo-4-hydroxyphenyl)methylene)-1,3-dihydro-5-iodo-2H-indol-2-one,
2H-Indol-2-one, 3-((3,5-dibromo-4-hydroxyphenyl)methylene)-1,3-dihydro-5-iodo-, (3Z)-,
3-[1-(3,5-Dibromo-4-hydroxy-phenyl)-meth-(Z)-ylidene]-5-iodo-1,3-dihydro-indol-2-one,
1233748-60-1,
D0Z5TQ,
cc-462,
2-hydrazinyl-2-oxo-N-phenylacetamide,
CID5924208,
GW 5074 (mixture of cis/trans isomers),
A11436,
C489251,
5-iodo-3-((3,5-dibromo-4-hydroxyphenyl)methylene)-2-indolinone,